• LevelJump Healthcare (JUMP) has closed a non-brokered private placement financing of 10 million units
  • Each unit consists of one common share of LevelJump and one common share purchase warrant
  • Each warrant entitles the holder to acquire one additional share for $0.20
  • LevelJump Healthcare Corp. (JUMP) owns and operates Canadian Teleradiology services
  • LevelJump Healthcare Corp. (JUMP) opened trading at C$0.195 per share

LevelJump Healthcare (JUMP) has closed a non-brokered private placement financing of 10 million units at a price of $0.15 per unit.

Gross proceeds from the offering totalled $1,500,000.

Each unit consists of one common share of LevelJump and one common share purchase warrant. Each warrant entitles the holder to acquire one additional share for $0.20 until March 31, 2024.

Proceeds from the financing will be directed towards acquisitions and for general working capital purposes.

The securities issued have a hold period of four months and one day from the closing date in accordance with applicable securities laws.

“We are really pleased with the market response to our offering, and the support of our strategic investors who believe in the vision of the company,” said Mitch Geisler, CEO.

“We have now strengthened our balance sheet. Given that our CTS subsidiary generates positive cash flow from its current operations we can designate this new capital towards growing the company.”

LevelJump Healthcare Corp. (JUMP) owns and operates Canadian Teleradiology services. JUMP plans to expand through the acquisition of independent healthcare facilities focused on diagnostic imaging as well as acquiring new disruptive imaging technologies.

LevelJump Healthcare Corp. (JUMP) opened trading at C$0.195 per share.

More From The Market Online

Reliq Health expands contract with U.S. health group

Reliq Health Technologies (TSXV:RHT) reveals it has expanded an existing contract with a large U.S. health group.

Telo Genomics and Emery Pharma collaborate

Telo Genomics (TSXV:TELO) collaborates with Emery Pharma to enhance cellular and molecular bioanalytical solutions for clinical research.

UniDoc brings AI to ER patients

UniDoc (CSE:UDOC) expands its AI partnership with DocBox, further integrating predictive analytics into emergency room operations.